Digital Health Chat

Gutsi is a digital gut-health platform that combines at-home microbiome testing with personalized insights and habit guidance.

Maximilian Schneider is the Co-Founder and CTO of Wholomics, an Austrian-American biotech company using metabolomics and AI to detect cancers at their earliest, most treatable stages. Wholomics' minimally invasive blood-based test has shown remarkable accuracy in identifying hard-to-detect cancers like pancreatic cancer, positioning the company at the forefront of the early-detection revolution.  

We sit down with Dr. Allan Böhm to explore how artificial intelligence and precision medicine are reshaping cardiovascular diagnostics and clinical care. Allan shares the story behind Seerlinq's AI platform, which analyzes subtle patterns in PPG signals to detect and monitor heart conditions non-invasively, and explains how Premedix Clinic is translating those innovations into everyday patient care. We discuss the challenges of building medically validated AI models, the importance of integrating research into clinical workflows, and what the next decade of digital cardiology could look like as technology and medicine converge.  

Charles Oyibo, is a principal at BigHeart Consulting and in this episode, we explore how BigHeart is transforming preventive healthcare through large-scale community engagement. Charles shares how the platform partnered with the State of Illinois to reach over 500,000 Medicaid recipients, activating them for screenings and preventive checkups through digital and in-person outreach. He explains how this model not only improves health outcomes but also reduces long-term costs for payers—creating a scalable blueprint for states and insurers seeking to close care gaps and drive population health impact.  

At DrSmile, Ivan Gammel supported growth from early stage to 500+ employees and 200 branches across Europe, leading to acquisition by Straumann Group as a CTO of the company. Unlike typical healthtech startups, DrSmile operated outside of the insurance system, but still encountered vendor gatekeeping, outdated integration standards, and unclear compliance frameworks.  

*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]" dir="auto" tabindex="-1" data-turn-id= "511b1643-6984-431c-a36c-1929d29d8a34" data-testid= "conversation-turn-2" data-scroll-anchor="true" data-turn= "assistant"> Ernesto brings decades of experience shaping healthcare strategies that expand patient access and accelerate the adoption of innovative medical technologies. Throughout his career, he has worked with both government bodies and leading global healthcare organizations, focusing on areas such as market access, strategic marketing, health economics, and reimbursement. His projects have spanned the US, Europe, Latin America, and the Middle East, helping healthcare companies position their products for success across diverse markets. As the CEO and Founder of ValueConnected, Ernesto leads a global team that combines expertise in AI and data science to solve critical challenges in healthcare—bridging the gap between innovation and real-world impact for patients, payers, and providers.